Company
OpenCell Technologies
SoftPoration™: Contactless gene delivery to hard-to-transfect cells
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- Life Science Industry
- opencelltech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
OpenCell Technologies™ provides efficient, high-throughput and scalable transfection tools to the Life Science Industry, enabling it to use difficult-to-transfect cells (e.g., primary and cancer stem cell cultures) in development of cell-based analysis techniques and discovery of new therapeutic cell-based therapies.
Funding snapshot
- Latest round
- Grant2019-09-01
Funding rounds
- Grant
- 2019-09-01
- Grant
- 2018-09-10
Products
- Hardware
- SoftPoration™
Loading relationship preview